Identifying risk factors for REM Sleep Behavior Disorder
Official title: Redictive Risk Factors of Conversion Into Idiopathic RBD. Italian Study [FAttori di Rischio PREdittivi di Conversione Nell'RBD Idiopatico. STudio ItalianO
Run by University of Cagliari · NCT05262543 · Data updated 2026-11-12
This study is trying to find out what factors might lead to people developing REM Sleep Behavior Disorder by looking at their sleep patterns and movements during sleep.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | University of Cagliari Academic / other |
| Locations | 2 sites (Oggebbio, Verbania and 1 other locations) |
| Status | Recruiting |
| Started | May 25, 2020 |
| Main results expected | March 31, 2025 |
| Study ends | January 31, 2035 |
| Registry record updated | March 26, 2024 |
| Trial ID | NCT05262543 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old diagnosed with idiopathic REM Sleep Behavior Disorder.
✕Probably not a fit
Patients who are unable to provide informed consent or have conditions that prevent them from participating in the study may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify predictive risk factors for the conversion into idiopathic REM Sleep Behavior Disorder (iRBD). Participants diagnosed with iRBD will undergo video-polysomnographic recording to assess the loss of muscle atonia during REM sleep and related motor behaviors. The study seeks to better understand the prevalence and characteristics of RBD, which is often underdiagnosed. By analyzing data from multiple Italian universities, the research will contribute to the understanding of this sleep disorder.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and management of REM Sleep Behavior Disorder, enhancing patient quality of life.
How similar studies have gone: While the exact approach may be novel, similar studies have indicated the importance of identifying risk factors in sleep disorders, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: major of 18 years old * iRBD diagnosis, according to diagnostic criteria of the ICSD second and third edition Exclusion Criteria: * Impossibility to provide or withdraw informed consent and inability to read, write and understand the purpose and modality of the study.
Where it's running
-
IRCCS Auxologico Piancavallo
Oggebbio, Verbania, Italy Recruiting -
Centro Interdipartimentale di Medicina del Sonno, Università degli studi di Cagliari
Cagliari, Italy Recruiting
Study contacts
- Principal investigator: Monica Puligheddu, MD,PhD — University of Cagliari
- Study coordinator: Monica Puligheddu, MD, PhD
- Email: centrosonnoca@unica.it
- Phone: 070 5109 6016
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder
This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.
-
Early PD signals in people with REM sleep behavior disorder
This study tests whether people with REM sleep behavior disorder show early signs of Parkinson’s disease before classic symptoms appear.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Multimodal prospective cohort of Parkinsonism
This project will try to track disease progression and improve diagnosis using imaging, clinical tests, and biological samples in people with parkinsonism, people with REM sleep behavior disorder, and healthy volunteers over five years.
-
Unmet needs of people with isolated REM sleep behavior disorder and their partners
This project asks people with isolated REM sleep behavior disorder (iRBD) and their significant others about their informational, emotional, and practical needs using online questionnaires.
-
Aiming to see if adalimumab can slow brain changes linked to synucleinopathy in people with REM sleep behavior disorder
This phase 2 trial tests whether the drug adalimumab, compared with placebo, can slow brain changes and progression toward Parkinson-like symptoms in people with idiopathic REM sleep behavior disorder.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.